A detailed history of Guardian Financial Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Guardian Financial Partners, LLC holds 832 shares of LLY stock, worth $751,054. This represents 0.62% of its overall portfolio holdings.

Number of Shares
832
Previous 999 16.72%
Holding current value
$751,054
Previous $777,000 3.09%
% of portfolio
0.62%
Previous 0.66%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$724.87 - $909.04 $121,053 - $151,809
-167 Reduced 16.72%
832 $753,000
Q1 2024

Apr 26, 2024

BUY
$592.2 - $792.28 $236,880 - $316,912
400 Added 66.78%
999 $777,000
Q4 2023

Jan 08, 2024

BUY
$525.19 - $619.13 $51,993 - $61,293
99 Added 19.8%
599 $349,000
Q3 2023

Oct 05, 2023

BUY
$434.7 - $599.3 $217,350 - $299,650
500 New
500 $268,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Guardian Financial Partners, LLC Portfolio

Follow Guardian Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Financial Partners, LLC with notifications on news.